CARDIOL THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.34 CAD | -3.11% |
|
-13.01% | +112.73% |
Chart calendar Cardiol Therapeutics Inc.
8606.owlUiTJCT7FwTko4KCwHl2JBOGfaS8Asfn4pWjiEwlQ.-lMx80QTftgYIg1uek5k1CQkCDXiO-1LMQZNLnDx8gLqRmDcejI90AEIJQ~25d8090be04355bec77362b59faada9f
Upcoming events on Cardiol Therapeutics Inc.
Past events on Cardiol Therapeutics Inc.
| 2024-04-01 06:41 pm | Q4 2023 Earnings Release |
| 2024-03-19 04:30 pm | Roth Conference |
| 2024-02-21 12:00 pm | International Investment Forum |
| 2023-11-14 | European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Meeting |
| 2023-11-14 04:39 pm | Q3 2023 Earnings Release |
| 2023-10-10 09:00 am | International Investment Forum |
| 2023-10-06 | Heart Failure Society of America Scientific Meeting |
| 2023-09-26 04:55 pm | Cantor Global Healthcare Conference |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-08-10 04:56 pm | Q2 2023 Earnings Release |
| 2023-08-10 11:00 am | Canaccord Genuity Growth Conference |
| 2023-06-28 04:30 pm | Annual General Meeting |
| 2023-05-15 04:16 pm | Q1 2023 Earnings Release |
| 2023-05-11 04:00 pm | Sidoti Micro-Cap Virtual Conference |
| 2023-03-28 06:31 pm | Q4 2022 Earnings Release |
| 2023-03-04 | American College of Cardiology Scientific with the World Cardiology Congress - Abnormal Mitochondria |
| 2023-03-03 | American College of Cardiology Scientific with the World Cardiology Congress - Cannabidiol Therapy f |
| 2023-02-15 08:30 am | International Investment Forum |
| 2022-11-10 04:26 pm | Q3 2022 Earnings Release |
| 2022-09-30 06:15 pm | Heart Failure Society of America Scientific Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,17 - | 0,08 0,45 -82.51% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -10,7 -10,6 -1.05% | -17,7 -11,6 -52.63% | -29,9 -22,5 -32.89% | -41,1 0,00 - | -29,5 -26,8 -10.27% | -28,0 |
|
EBIT Million CAD | Released Forecast Spread | -14,0 -14,1 0.88% | -20,5 -14,4 -42.72% | -38,7 -29,5 -30.91% | -41,3 -39,0 -5.96% | -29,8 -28,5 -4.51% | -36,2 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -13,7 -14,2 3.63% | -20,6 -14,6 -41.06% | -31,6 -33,9 6.55% | -30,9 -33,0 6.33% | -28,1 -28,1 -0.28% | -36,2 |
|
Net income Million CAD | Released Forecast Spread | -13,7 -14,2 3.63% | -20,6 -14,6 -41.06% | -31,6 -33,9 6.55% | -30,9 -33,0 6.33% | -28,1 -28,1 -0.28% | -36,2 |
|
EPS CAD | Released Forecast Spread | -0,53 -0,55 3.64% | -0,69 -0,45 -53.33% | -0,73 -0,74 1.35% | -0,49 -0,53 6.67% | -0,44 -0,44 -1.15% | -0,52 |
| Announcement Date | 26/03/20 | 31/03/21 | 23/03/22 | 28/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -8,45 -5,80 -45.75% | -9,18 -10,7 14.22% | |||||||||||
|
EBIT Million CAD | Released Forecast Spread | -13,1 -8,84 -48.17% | -9,79 -11,5 14.88% | -9,23 -9,75 5.33% | -13,2 -9,59 -37.88% | -9,10 -6,79 -33.96% | -7,79 -9,49 17.92% | -6,31 -8,11 22.14% | -7,66 -7,60 -0.74% | -8,03 -8,20 2.09% | -8,60 | -9,10 | -9,50 | -9,00 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -6,26 -8,36 25.19% | -8,95 -10,8 17.09% | -6,49 -9,33 30.43% | -7,97 -9,21 13.47% | -7,52 -9,61 21.84% | -7,09 -9,46 25.07% | -7,47 -8,09 7.59% | -5,93 -7,60 21.97% | -7,64 -8,00 4.54% | -8,60 | -9,10 | -9,50 | -9,00 |
|
Net income Million CAD | Released Forecast Spread | -6,26 -8,36 25.19% | -8,95 -10,8 17.09% | -6,49 -9,33 30.43% | -7,97 -9,21 13.47% | -7,52 -9,61 21.84% | -7,09 -9,46 25.07% | -7,47 -8,09 7.59% | -5,93 -7,60 21.97% | -7,64 -8,00 4.54% | -8,60 | -9,10 | -9,50 | -9,00 |
|
EPS CAD | Released Forecast Spread | -0,11 -0,15 24.14% | -0,14 -0,17 17.65% | -0,10 -0,15 33.33% | -0,13 -0,15 10.34% | -0,11 -0,16 29.03% | -0,11 -0,15 26.67% | -0,12 -0,13 4% | -0,09 -0,12 25% | -0,12 -0,12 0% | -0,13 | -0,14 | -0,14 | -0,12 |
| Announcement Date | 23/03/22 | 16/05/22 | 10/08/22 | 10/11/22 | 28/03/23 | 15/05/23 | 10/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
More events
Past sector events for Cardiol Therapeutics Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRDL Stock
- Calendar Cardiol Therapeutics Inc.
